Serum total protein, albumin and advanced oxidation protein products (AOPP) - implications in oral squamous cell carcinoma

Malaysian Journal of Pathology

Volumn 34, Issue 1, 2012, Pages 47-52

  Nayyar, Abhishek Singh ^a   Khan, Mubeen ^a   Vijayalakshmi, K R ^a   Suman, B ^a   Gayitri, H C ^a   Anitha, M ^b  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

^b Bangalore Medical College and Research Institute ^*  (India)

Author keywords

Oral squamous cell carcinoma; Pre cancerous; Reactive oxygen species; Serum albumin; Transformation

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ALBUMIN; OXYGEN RADICAL;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CARCINOGENESIS; CHEMICAL ANALYSIS; CLINICAL EXAMINATION; CONTROLLED STUDY; HISTOLOGY; HUMAN; LEUKOPLAKIA; MOUTH SQUAMOUS CELL CARCINOMA; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; CARCINOMA, SQUAMOUS CELL; HUMANS; LEUKOPLAKIA, ORAL; MIDDLE AGED; MOUTH NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN;

EID: 84863316604     PISSN: 01268635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kolanjiappan K, Ramachandran CR, Manoharan S. Biochemical changes in tumor tissues of oral cancer patients. Clin Biochem. 2003;36(1):61-5.
2. Hershkovich O, Shafat I, Nagler RM. Age-related changes in salivary antioxidant profile: possible implications for oral cancer. J Gerontol A Biol Sci Med Sci. 2007;62(4):361-6.
3. Storz P. Reactive oxygen species in tumor progression. Front Biosci. 2005;10:1881-96.
4. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: Induction, repair and significance. Mutat Res. 2004;567(1):1-61.
5. von Sonntag C. Free radical-induced DNA damage and its repair: A chemical perspective. Basle: Springer; 2006.
6. Halliwell B, Gutteridge J. Free radicals in biology and medicine. 4th ed. Oxford: Clarendon Press; 2007.
7. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991;51(3):794-8.
8. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995;358(1):1-3.
9. Oberley TD. Oxidative damage and cancer. Am J Pathol. 2002;160(2):403-8.
10. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004;44:239-67.
11. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160(1):1-40.
12. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004;7(2):97-110.
13. Elango N, Samuel S, Chinnakkannu P. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: Influence of selenium supplementation. Clin Chim Acta. 2006;373(1-2):92-8.
14. Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer. 2007;109(1):54-9.
15. Engel RH, Evens AM. Oxidative stress and apoptosis: A new treatment paradigm in cancer. Front Biosci. 2006;11:300-12.
16. Iwao Y, Anraku M, Hiraike M, et al. The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). Drug Metab Pharmacokinet. 2006;21(2):140-6.
17. Demirbilek ME, Kilic N, Komurcu HF, Akin KO. Advanced oxidant protein products in aged with dementia. Am J Immunol. 2007;3(2):52-5.
18. Ihara H, Hashizume N, Hasegawa T, Yoshida M. Antioxidant capacities of ascorbic acid, uric acid, alpha-tocopherol, and bilirubin can be measured in the presence of another antioxidant, serum albumin. J Clin Lab Anal. 2004;18(1):45-9.
19. Barle H, Hammarqvist F, Westman B, et al. Synthesis rates of total liver protein and albumin are both increased in patients with an acute inflammatory response. Clin Sci (Lond). 2006;110(1):93-9.
20. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85(4):599-610.
21. Zoellner H, Hofler M, Beckmann R, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci. 1996;109 (Pt 10):2571-80.
22. Kouoh F, Gressier B, Luyckx M, et al. Antioxidant properties of albumin: Effect on oxidative metabolism of human neutrophil granulocytes. Farmaco. 1999;54(10):695-9.
23. James WP, Hay AM. Albumin metabolism: Effect of the nutritional state and the dietary protein intake. J Clin Invest. 1968;47(9):1958-72.
24. Soejima A, Matsuzawa N, Hayashi T, et al. Alteration of redox state of human serum albumin before and after hemodialysis. Blood Purif. 2004;22(6):525-9.
25. Himmelfarb J, McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 2001;60(1):358-63.
26. Witko-Sarsat V, Nguyen-Khoa T, Jungers P, Drueke TB, Descamps-Latscha B. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant. 1999;14 Suppl 1:76-8.
27. Selmeci L, Seres L, Antal M, Lukacs J, Regoly-Merei A, Acsady G. Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: A simple, fast and inexpensive automated technique. Clin Chem Lab Med. 2005;43(3):294-7.
28. Liu SX, Hou FF, Guo ZJ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol. 2006;26(5):1156-62.
29. Servettaz A, Guilpain P, Goulvestre C, et al. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis. Ann Rheum Dis. 2007;66(9):1202-9.
30. Baskol M, Baskol G, Kocer D, Ozbakir O, Yucesoy M. Advanced oxidation protein products: A novel marker of oxidative stress in ulcerative colitis. J Clin Gastroenterol. 2008;42(6):68
31. Shi XY, Hou FF, Niu HX, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology. 2008;149(4):1829-39.
32. Alev K, Aysun T, Hatice S, et al. Advanced glycation end-products and advanced oxidation protein products in patients with insulin dependent diabetes mellitus and first degree relatives. Baki{dotless}rköy Ti{dotless}p Dergisi. 2011;7:130-5.